Thymic stromal lymphopoietin (TSLP) is produced by epithelial cells and keratinocytes, and is involved in immune
INTRODUCTION
Thymic stromal lymphopoietin (TSLP) is a cytokine initially isolated from a mouse thymic stromal cell line 1 and described to be a lymphocyte growth factor. 2 TSLP has been shown to be produced also by keratinocytes and epithelial cells 3 in response to several stimuli, including bacteria, parasites, and inflammatory cytokines, via a nuclear factor (NF)-b-dependent pathway. 4 ,5 TSLP levels are increased at sites of inflammation and have been shown to correlate with several pathologies, including atopic dermatitis, allergy, asthma, and recently also cancer. 6 -10 Similarly, overexpression of TSLP in keratinocytes or lung epithelial cells in the mouse has been correlated with allergic skin reactions and asthma, respectively. 11 -13 TSLP signals via its heterodimeric receptor composed by a TSLP receptor (TSLPR) chain (that is closely related to the common -chain) and the interleukin (IL)-7R -chain. 14 Studies on TSLPR-deficient mice have shown that TSLPR expression on CD4 + T cells is required for the differentiation and pathological effects of Th2T cells. 2,12,13 A direct effect of TSLP on murine T cells was demonstrated in vitro as CD4 + T cells responded to TSLP by inducing STAT5 phosphorylation, GATA3 expression, and Th2 cytokine production. 15 The role of TSLPR in human T cells is still debated, as na ï ve CD4 + T cells display very little expression of TSLPR although they can upregulate it during activation but not at levels similar to those expressed by dendritic cells (DCs). 16, 17 In addition, TSLP does not directly induce the development of Th2 T cells in the human system. 16 TSLP is produced also by mouse and human resting intestinal epithelial cells 18 -20 and its expression in vitro has been shown to be regulated by commensal or probiotic bacteria. 21, 22 TSLP expression by intestinal epithelial cells is fundamental for the inhibition of IL-12 production by DCs both in the mouse and in the human system. 19, 20 In addition, TSLP is required for the generation of tolerogenic DCs capable of inducing T-regulatory cells expressing Foxp3 in the human but not in the mouse system. 23 -25 Further, TSLP can induce the expression of secretory leukocyte peptidase inhibitor, an endogenous inhibitor of neutrophil elastase. 26 Hence, besides pro-inflammatory activity, TSLP seems to have a role in the physiological function of the gut by promoting a noninflammatory and tolerogenic environment. Indeed, we have shown that epithelial cells from a vast majority of Crohn ' s disease patients fail to promote tolerogenic DCs and this correlates with a reduced expression of TSLP. 20, 24 It has been shown that mice deficient for TSLPR display an increased Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis ARTICLES susceptibility to Trichuris muris infection and experimental colitis; 18 however, the role of TSLP in controlling intestinal inflammation in the mouse system remains elusive, particularly in light of the recent finding that DCs also can produce TSLP. 27 Here, we confirm that mouse DCs express TSLP both in vitro and in vivo in response to Toll-like receptor (TLR) ligation in a MyD88-dependent fashion. We show that DC-derived TSLP limits Th17 polarization and fosters Foxp3 + Treg development. Consistently, adoptive transfer of na ï ve T cells from TSLPR − / − to SCID mice results in a more severe pathology.
RESULTS

TSLP is required to protect the gut from inflammation
We recently described that while in the human system TSLP is involved in controlling the differentiation of gut tolerogenic DCs, 24 in the mouse system epithelial cell-derived TSLP is dispensable to drive CD103 + tolerogenic DCs. 23 Hence, whether TSLP has a role in intestinal inflammation in the mouse system remains elusive. We addressed this issue by testing the susceptibility of TSLPR − / − to experimental colitis. TSLPR − / − and control mice were treated for 7 days with 5 % dextran sodium sulfate (DSS) and were then followed for the development of colitis and cytokine production in the intestine. Progression of the disease was monitored by body weight loss, diarrhea, and the appearance of blood in the feces. As shown in Figure 1 , TSLPR − / − mice displayed an increased susceptibility to colitis, as attested by a more pronounced weight loss ( Figure 1a ) and disease activity index ( Figure 1b ). Histopathological analysis confirmed the increased severity of the disease in TSLPR − / − mice as they displayed an altered histology, including focal crypt epithelial destruction and extensive areas of epithelial hyperplasia associated with mononuclear infiltrates ( Figure 1c ). The colons of mice also displayed an increased frequency of CD4 + interferon (IFN)-+ and IL-17 + T cells ( Figure 1d , Supplementary Figure S1 ), and statistically significant higher levels of pro-inflammatory cytokines, such as IFN-and tumor necrosis factor- ( Figure 1e ) . Surprisingly, we also found an increase of the Th2 cytokine IL-13 ( Figure 1e ). IL-17 was upregulated but the difference did not reach statistical significance ( Figure 1e ). Hence, TSLP signaling is required to preserve intestinal homeostasis; however, as we have shown that TSLP is not involved in driving tolerogenic DCs, the mechanism remains elusive.
TSLPR expression on T cells is required to protect against colitis
As shown above, TSLPR − / − mice show an increased susceptibility to DSS colitis. As TSLP is not involved in driving tolerogenic DCs, 23 we postulated that it may be due to a direct effect of TSLP on T cells as TSLPR expression on T cells is required for some pathological effects of TSLP. 2, 12, 13 To evaluate this possibility, we used an adoptive T-cell transfer model of colitis by reconstituting SCID mice with na ï ve CD4 + CD25 − CD45RB hi T cells isolated either from wild-type (WT) or from TSLPR − / − mice. In this way the only cells lacking TSLPR would be T cells. Mice were weekly monitored for signs of colitis and nearly 2 months later they were killed. Colons were collected and analyzed for lymphocyte infiltrates and expression of inflammatory cytokines. We found that mice receiving TSLPR − / − T cells displayed a more severe colitis as assessed by the histopathological analysis of the colons ( Figure 2a ). Tissue sections from TSLPR − / − mice exhibited increased inflammatory cell infiltrate and extensive areas of epithelial hyperplasia ( Figure 2a ). SCID mice adoptively transferred with TSLPR − / − T cells displayed a similar amount of IFN--producing T cells but a marked increase of IL-17-producing T cells ( Figure 2b , Supplementary Figure S2 ) . Similarly, the expression of inflammatory cytokines as assessed by quantitative PCR of colon homogenates was drastically increased in mice receiving TSLPR − / − T cells ( Figure 2c ). In particular, we observed a statistically significant increase in il17a, il4, il6 , and cox2 gene expression, but not in ifn-where the increase did not reach statistical significance. This observation suggests that TSLP is involved in controlling IL-17 production by T cells and proposes a new anti-inflammatory role of TSLP on T cells.
Mouse DCs express TSLP
Having shown that TSLP has a protective role against colitis through a direct action on T cells, we wondered whether also DCs expressed TSLP and this could be the source of T-cell-acting TSLP. We evaluated the expression of TSLP by bone marrow-derived DCs (BMDCs) after maturation induced by several TLR ligands. We found that BMDCs expressed TSLP messenger RNA and that TLR triggering resulted in TSLP upregulation ( Figure 3a ) . We found that lipopolysaccharide (LPS) was the most powerful inducer of TSLP expression, hence we used this stimulus for subsequent experiments. LPS can trigger two intracellular pathways, one is dependent on the adaptor protein MyD88 and the other on TRIF. 28 Hence, we then evaluated whether the induction of TSLP expression by LPS was dependent on MyD88 by using BMDCs from MyD88 − / − mice. We found that lack of MyD88 signaling abrogated LPS-induced TSLP expression ( Figure 3b ). To assess whether TSLP protein was expressed, BMDCs were treated or not with LPS and lysed. TSLP protein was immunoprecipitated and analyzed by western blot. Paralleling the quantitative PCR results, we detected enhanced TSLP production in LPS-treated BMDCs ( Figure 3c ). We then evaluated whether DCs expressed TSLP also in vivo . Mice were injected intravenously with LPS and after 24 h CD11c + DCs were isolated from spleens. TSLP was detected in splenic DCs only after LPS treatment ( Figure 3c ). Hence, in vitro and in vivo , DCs express TSLP after LPS stimulation via a MyD88-dependent pathway. This is likely occurring via LPS-induced NF-kB activation as an active NF-kB binding site has been described on the TSLP gene promoter. 4
DC-derived TSLP controls Th17 and Treg cell development
It has been described that TSLP has an important role in driving Th2-promoting DCs by inhibiting IL-12 production, both in the mouse and human system. 6, 19, 20 In addition, in mice, TSLP can act directly on T cells by inducing IL-4 production. 15 Hence, we investigated whether DC-produced TSLP had an effect in the capacity of T cells to produce cytokines. BMDCs generated from femurs of C57 / BL6 mice were activated or not with ARTICLES LPS and incubated with na ï ve T cells from TSLPR − / − Balb / c mice in an allogeneic mixed leukocyte reaction. Intracellular cytokine staining was carried out on activated T cells while IL production in the culture medium was tested by cytokine bead array. We found that lack of TSLPR on T cells was associated to an increased differentiation of Th17 T cells in response to LPS-stimulated WT DCs as attested by intracellular cytokine staining ( Figure 4a ). We also found a reduced differentiation of CD4 + T cells expressing Foxp3 ( Figure 4b ). This correlated with an increased production of protein and messenger RNA for IL-17A, and reduced release of IL-13 and IL-10 ( Figure 5 ). We could not detect any differences in IFN-release by T cells ( Figure 5a ), even though we had observed that non-treated DCs induced an increased percentage of IFN--producing WT T cells as compared with TSLPR − / − T cells ( Figure 4a ). However, as WT T cells displayed a reduced mean fluorescence intensity of cytokine production as compared with TSLPR − / − T cells, it is likely that a lower number of cells with a higher expression may release a similar amount of IFN-than a higher number of cells but at a lower expression. IL-4 was not induced after LPS stimulation and we could not detect much difference in T-cell cultures from TSLPR − / − or WT mice ( Figure 5 ). This suggests that in response to LPS, DC-derived TSLP does not skew Th2 T-cell polarization and this differs from the direct action of TSLP on T cells in the absence of other stimulations. 15 Altogether, these results suggest that DC-produced TSLP acts on T cells by 
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limiting their differentiation to Th17, while fostering the development of Foxp3 + T cells.
TSLP acts directly on T cells to inhibit Th17 cell development
As also DCs express the TSLPR, we could not exclude a possible autocrine effect of TSLP on DCs allowing then the T cells to respond to TSLP. Thus, we analyzed the effect of TSLP in T-cell polarization to Th17 in an antigen presenting cell-free assay. TSLPR − / − and WT T cells were stimulated in vitro with anti-CD3 / CD28 in the presence or absence of transforming growth factor (TGF)-and IL-6 to promote or not Th17 differentiation, and cells were co-incubated with increasing doses of TSLP. Cytokine release was analyzed by cytokine bead array in 48-h culture supernatants, while gene expression was evaluated by quantitative PCR on RNA extracted from T cells. As shown in Figure 6 and Supplementary Figure S3 , Th17 differentiation was strongly affected by TSLP in a dose-dependent fashion, even though at the highest dose of 20 ng ml − 1 the effect was less prominent. In agreement with previous data, 15 the addition of TSLP in the absence of Th17-polarizing cytokines fostered the development of Th2 T-cell cytokines (IL-4, IL-5, and IL-13), but we could also observe an increase in IFN-and IL-17 production ( Figure 6 ). Together, these results suggest that TSLP induces Th2 and inhibits Th17 differentiation acting directly on T cells and not in an autocrine fashion on DCs.
CD103 + DCs express TSLP in the gut
In the gut, two populations of mononuclear phagocytes have been described that can be distinguished based on the expression of the E integrin CD103. 29 -31 It has been shown that CD103 + DCs are capable to migrate to the mesenteric lymph node and to drive T-regulatory cell differentiation, 32, 33 while CD103 − cells resemble macrophages and are resident in the gut. 34 Moreover, it has been described that CD103 + DCs isolated from colitic mice lose their tolerogenic properties and are capable to foster Th1 and Th17 T-cell differentiation. 35 Hence, we first compared the level of expression of TSLP in cells isolated from intestinal tissues (colon): CD103 + DCs, CD103 − mononuclear phagocytes, and epithelial cells. We found that CD103 + DCs expressed twice as much TSLP than CD103 − phagocytes and nearly similar levels than epithelial cells ( Supplementary Figure S4 ) . We also observed that after DSS colitis while the 
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expression of TSLP by CD103 − cells remained unaltered, it was drastically reduced in CD103 + DCs ( Figure 7a ). This seems to contradict the data that TSLP expression is induced by TLR ligation; however, it is known that lamina propria phagocytes (particularly macrophages, CD103 − ) are refractory to stimulation by most TLR ligands while CD103 + DCs already have a more activated phenotype. 32, 36, 37 This may explain why CD103 − cells do not upregulate TSLP while CD103 + cells already express it.
We cannot explain why CD103 + DC downregulates TSLP in response to DSS. We then analyzed the role of TSLP expressed by CD103 + DCs in T-cell activation. cytokine staining. Consistent with a role of TSLP in fostering Treg cell development, we observed a drastic reduction in Treg differentiation by CD103 + DCs when T cells lacked TSLPR signaling ( Figure 7b ). No major differences were observed when stimulating with CD103 − cells. While we could not observe a significant difference in either IFN-or IL-17 single producing T cells, we observed a significant increase in IFN-/ IL-17 double producing TSLPR − / − T effector cells after stimulation with CD103 + DCs. This suggests that, in the absence of TSLP signaling, T cells are prone to differentiate more into inflammatory and less into regulatory cells.
DISCUSSION
Here, we have confirmed the very recent finding that DCs can produce the highly relevant cytokine TSLP 27 that is involved in both physiological and pathological processes at mucosal surfaces and the skin. Our findings highlight an unanticipated function of TSLP in controlling intestinal homeostasis. DC-derived TSLP is important in regulating the development of Th17 and Treg cells acting directly on TSLPR expressed on T cells. This may be another feedback mechanism initiated by DCs to limit inflammation after TLR ligation. It has been recently shown that low doses of TSLP are capable of inhibiting de novo induction of Tregs without significantly promoting Th2 development; 38 it is likely that DCs by upregulating TSLP after LPS triggering may skew towards Treg induction while limiting Th17 T-cell differentiation and thus constraint inflammation. By contrast, in the gut, CD103 + DCs already express higher levels of TSLP, promote Treg induction, and limit Th17 differentiation even in the absence of direct TLR stimulation. This has a physiological 
Figure 6
Thymic stromal lymphopoietin (TSLP) inhibits IL17 production in a dose-dependent manner. 2.5 × 10 5 mouse splenic CD4 + CD25 − T cells were cultured in presence or absence of Th17-driving cytokines (5 ng ml − 1 transforming growth factor (TGF)-1 and 20 ng ml − 1 interleukin (IL)-6) with or without different concentrations of TSLP. The concentrations used were: 0.2, 1, 5, 10, or 20 ng ml − 1 . After 48 h, supernatants from the cultures were harvested and cytokine production was measured by cytokine bead array. Results represent means ± s.e.m. Data represent three independent experiments. * P < 0.05, * * P < 0.01, * * * P < 0.001. IFN, interferon.
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role in protecting against inflammation as mice adoptively transferred with TSLPR − / − T cells exhibit an increased susceptibility to experimental colitis and elevated Th17 T cells in the inflamed colons. We have not addressed here a possible autocrine role of TSLP on the DC themselves, which is likely to occur as TSLP can control the release of IL-12 by DCs and limits the development of Th1 T cells. 19, 20 In fact, we have shown that TSLPR − / − mice are more susceptible to colitis and display increased levels of Th1 cytokines in the inflamed colons. Hence, it is possible that TSLP can act both on DCs by limiting their potential to drive Th1 T cells and on T cells by controlling their differentiation to Th2, Th17, and Tregs. In addition, TSLP has been shown to induce in an autocrine fashion the expression of secretory leukocyte peptidase inhibitor, an endogenous inhibitor of neutrophil elastase that has been shown to be required for the recovery phase after DSS treatment. 26 Interestingly, after DSS-induced colitis, TSLP expression in CD103 + DCs is drastically reduced while in CD103 − mononuclear phagocytic cells it is not upregulated. The reason for this is not known, but it may be due to the inability of lamina propria phagocytes to respond to ligation to most TLRs. 37 We found that TSLP produced by CD103 + DCs is required for the differentiation of Foxp3 + Tregs and when T cells lack this signaling the differentiation of IL-17 / IFN-+ T cells is fostered.
Although the exact role of IL-17 / IFN-+ T cells in the pathogenesis of colitis is not yet clear, it has been shown that these T cells express the IL-23R and accumulate in the lamina propria of patients with Crohn ' s disease. 39 Interestingly, IL-23R signaling in T cells is involved in reducing the differentiation of Foxp3 + Tregs and in the emergence of IL-17 / IFN-+ T cells. 40 It would be interesting to evaluate whether the cells that emerge in the absence of TSLPR signaling have upregulated the IL-23R. Our preliminary data indicate that TSLP is produced also by human DCs; thus, it would be interesting to evaluate whether in the human system DC-derived TSLP participates in limiting Th17 cell development and controlling intestinal inflammation. Finally, in light of the recent findings that TSLP can be involved in the recruitment of basophils in response to T. muris infection 41 or that TSLP is chemotactic for the DC themselves, 42 DCs may mediate immune cell recruitment after their activation either in the periphery or draining lymph nodes, and thus further participate in the amplification of the immune response.
In conclusion, we have shown that DCs produce TSLP that can act directly on T cells by controlling their differentiation to Th17 and Tregs cells; this has important consequences on intestinal inflammation.
METHODS
Mice and cells. The 6 -8-week-old WT C57BL / 6J, BALB / c, and SCID mice were purchased from Harlan Laboratories (Milan, Italy). BALB / c TSLPR − / − mice were provided by Dr W.J. Leonard (Laboratory of Molecular Immunology, NHLBI, USA). MyD88 − / − mice were obtained by Dr S Akira (Osaka University, Japan). Mice were bred and maintained at IFOM-IEO Campus animal facility under specific pathogen-free conditions. All experiments were performed in accordance with the guidelines established in the Principles of Laboratory Animal Care (directive 86 / 609 / EEC). Mode-k cells were kindly provided by Dr D. Kaiserlian. 43 
Isolation of DCs and endothelial cells from colonic lamina propria.
Colon tissue was cut into small pieces and incubated in PBS containing 1 % fetal bovine serum, 1-m M dithiothreitol, and 1-m M ethylene- RNA isolation and quantitation of gene expression by real-time PCR. Total RNA was purified from cells using RNeasy Kits (Qiagen, Hilden, Germany). Complementary DNA synthesis was performed using SuperScript III reverse transcriptase (Invitrogen) and random hexamers. Real-time PCR reactions were carried out using the SYBR Green PCR kit and the primers listed in Table 1 on the Applied Biosystems 7500 Fast Real-Time PCR System (Applied Biosystems, Carlsbad, CA). Expression levels for each sample were normalized to the expression levels of Rpl32 or Tbp . Results were quantified using the 2 − Ct method. 44 Allogeneic DC / T-cell cocultures. A total of 2 × 10 4 BMDCs from C57BL / 6J mice, activated with LPS as previously described, or 2 × 10 4 DCs isolated from Mesenteric Lymph Nodes (MLNs), were cocultured for 6 days with 10 5 CD4 + CD25 − T cells purified according to manufacturer ' s instructions (Miltenyi Biotec) from spleens of WT or TSLPR − / − BALB / c mice. In some experiments, 2 ng ml − 1 of human recombinant TGF-1 (R & D Systems) was added at day 3 of coculture. After 4 days of culture, cells were stained for CD4 (BD Biosciences) and for Foxp3 (eBioscience, San Diego, CA) after permeabilization according to the manufacturer ' s protocol. At day 6, supernatants were collected and were analyzed for cytokines content using cytokine bead array Flex Set System (BD Biosciences). Cells from the cocultures were incubated with 50 ng ml − 1 PMA, 500 ng ml − 1 ionomycin, and Golgistop for 4 -5 h. Lymphocytes were permeabilized using the Cytofix / Cytoperm Kit (BD Biosciences), and stained for CD4 (BD Biosciences), IFN-(BD Biosciences), and IL-17 (BD Biosciences).
DSS-induced colitis.
Colitis was induced by adding 5 % (w / v) DSS (TdB Consultancy AB, Uppsala, Sweden) to drinking water for 7 days. Mice were monitored daily for weight loss, stool consistency, and fecal occult blood (Hemoccult, Beckman Coulter, Milan, Italy). Severity of colitis was evaluated measuring the disease activity index, which was calculated as previously described. 45 T-cell transfer model of colitis. SCID mice were injected intraperitoneally with 4 × 10 5 CD4 + CD25 − CD45RB hi T cells isolated from spleens of WT or TSLPR − / − BALB / c mice. In brief, enriched CD4 + singlecell suspensions were stained with phycoerythrin-conjugated anti-CD4, antigen presenting cells-conjugated anti-CD25, and fluorescein isothiocyanate-anti-CD45RB (all purchased from BD Biosciences). Na ï ve CD4 + CD25 − CD45RB hi T cells were purified with a cell sorter (FACSAria, BD Biosciences). After T-cell reconstitution, mice were monitored for weight loss and for severe signs of colitis every 5 days. Mice were killed 50 days after T-cell adoptive transfer, and colon samples were immediately fixed in Hollandes Fixative (Polysciences, Eppelheim, Germany). The 5-m paraffin-embedded colon sections were cut, and stained with hematoxylin and eosin. Inflammation was assessed in a blinded fashion.
Histology scoring system. The number of inflammatory cells (macrophages, lymphocytes, and plasma cells, and neutrophils) was evaluated by using a visual analogue scale modified for murine intestinal Table 1 Primer table   Gene Sense (5 Ј -3 Ј ) Antisense (3 Ј -5 Ј )
Tbp
CTACCGTGAATCTTGGCTGT GTTGTCCGTGGCTCTCTTAT
Rpl32
AAGCGAAACTGGCGGAAAC TAACCGATGTTGGGCATCAG
Tslp
CTGAGAGAAATGACGGTACTCAGG GGAGATTGCATGAAGGAATACCAC
Il17a
GGACTCTCCACCGCAATGA GGCACTGAGCTTCCCAGATC
Il17f
CCCCATGGGATTACAACATCAC CATTGATGCAGCCTGAGTGTCT
Ifng
TCAAGTGGCATAGATGTGGAAGAA TGGCTCTGCAGGATTTTCATG
Il6
CCATAGCTACCTGGAGTACATG TGGAAATTGGGGTAGGAAGGAC
Rorc
GGAGGACAGGGAGCCAAGTT CCGTAGTGGATCCCAGATGACT
Il4
GGCATTTTGAACGAGGTCACA GACGTTTGGCACATCCATCTC
Cox2
CCACTTCAAGGGAGTCTGGA AGTCATCTGCTACGGGAGGA ARTICLES specimens, and results were reported as the mean for the entire specimen. When considerable variation of intensity of infiltration was evident in the same specimen, the mean for several areas is determined and the specimen scored accordingly. Neutrophils and mononuclear cells were classified as absent (score 0) when there was none or only single sporadic cells per high-power field (HPF, using original magnification × 400) ( < 5 cells), mild (score 1) for a few cells (5 -49 cells) per HPF, moderate (score 2) for several cells (50 -99 cells) per HPF, and severe (score 3) for numerous cells (100 -200 cells or more) per HPF. Histological criteria for normal or paraphysiological intestinal characteristics included detection of none or only a few mononuclear cells per HPF in perivascular area, and none or only a few scattered neutrophils interspersed throughout the mucosal corion without tissue changes (no sub-epithelial hyperemia or edema, and absence of any lymphoid aggregate, follicular in shape, in the lamina propria thickness; epithelial layer and glandular lumina / crypt free from exudate).
Quantitation of cytokine production in colonic tissues. Fresh colonic samples (1 cm) were cultured in RPMI 1640 supplemented with 100 U ml − 1 penicillin, 100 g ml − 1 streptomycin, 100 g ml − 1 gentamicin, and 25 g ml − 1 amphotericin B for 24 h. Frozen colonic tissues (1 cm) were homogenized in TRIzol (Invitrogen), and total RNA was precipitated according to manufacturer ' s instructions. To further purify RNA from tissues, RNeasy Mini Kit (Qiagen) was used. Complementary DNA synthesis and real-time PCR reactions were carried out as previously described. Samples were analyzed for the expression of Il17a , Ifn , Il4 , Il6 , and Cox2 , using the primers listed in Table 1 . Lymphocytes were then permeabilized using the Cytofix / Cytoperm Kit, and stained for CD4, IFN-, and IL-17.
